Pharmaceutical Outcomes and Policy
Identifying and improving the economic and health outcomes of therapies, policies and practices
The Division of Pharmaceutical Outcomes and Policy (DPOP) prepares graduates for leadership positions in academia, industry, and government sectors. Students develop solid research skills, enabling them to conduct high quality research directed at improving the use and cost-effectiveness of pharmaceutical products, technology, and services in society.
Our faculty are trained in public health and have expertise in: pharmacoepidemiology, genomic epidemiology, health behavior and behavior change (including the effects of patient-provider communication, risk communication, and health literacy on health behavior), comparative effectiveness research, pharmaceutical policy, and pharmacoeconomics.
We are training our students in the effectiveness and costs of medications, how patients take their medications, and the impact of drug policies on health outcomes of vulnerable people. Our PhD program offers three different concentrations: Pharmaceutical Policy and Economics, Pharmaco-Epidemiology and Social and Behavioral Health.
DPOP is committed to excellence in research, education, and service that advances the optimal use of medications with the goal of improving human health. Our research focuses on health outcomes and how to support medication taking at the individual, practice, and system level.
Associate Professor Carolyn Thorpe, Ph.D., M.P.H., has been awarded more than $2.5 million from the National Institute on Aging to support her project entitled, “Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer’s Disease and Related Dementias”. As principal investigator, Thorpe will lead an interdisciplinary team from UNC-Chapel Hill, the VA Pittsburgh Healthcare System, the University of Pittsburgh and the University of New England in conducting a retrospective cohort study using real-world health care data from the Veterans Health Administration. The study will use rigorous pharmaco-epidemiologic methods to examine patterns, benefits, and harms of discontinuing aspirin in older nursing home residents with Alzheimer’s Disease and Related Dementias.
Congratulations to Dr. Betsy Sleath for being featured in the Well for her work in health care communication.
Congratulations to Dr. Delesha Carpenter for expanding RURAL-CP, the first rural community pharmacy practice-based research network, to Tennessee and Georgia. The network now includes pharmacies in 7 southeastern states.